CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanoma.
Journal
Oncogene
ISSN: 1476-5594
Titre abrégé: Oncogene
Pays: England
ID NLM: 8711562
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
26
03
2020
accepted:
23
03
2021
revised:
10
03
2021
pubmed:
10
4
2021
medline:
17
12
2021
entrez:
9
4
2021
Statut:
ppublish
Résumé
MicroRNAs and RNA-binding proteins (RBPs) primarily target the 3' UTR of mRNAs to control their translation and stability. However, their co-regulatory effects on specific mRNAs in physiology and disease are yet to be fully explored. CSDE1 is an RBP that promotes metastasis in melanoma and mechanisms underlying its oncogenic activities need to be completely defined. Here we report that CSDE1 interacts with specific miRNA-induced silencing complexes (miRISC) in melanoma. We find an association of CSDE1 with AGO2, the essential component of miRISC, which is facilitated by target mRNAs and depends on the first cold shock domain of CSDE1. Both CSDE1 and AGO2 bind to 3' UTR of PMEPA1. CSDE1 counters AGO2 binding, leading to an increase of PMEPA1 expression. We also identify a miRNA, miR-129-5p, that represses PMEPA1 expression in melanoma. Collectively, our results show that PMEPA1 promotes tumorigenic traits and that CSDE1 along with miR-129-5p/AGO2 miRISC act antagonistically to fine-tune PMEPA1 expression toward the progression of melanoma.
Identifiants
pubmed: 33833398
doi: 10.1038/s41388-021-01767-9
pii: 10.1038/s41388-021-01767-9
doi:
Substances chimiques
Argonaute Proteins
0
MicroRNAs
0
RNA, Messenger
0
RNA-Binding Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3231-3244Références
Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92–105.
pubmed: 18955434
pmcid: 2612969
doi: 10.1101/gr.082701.108
Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol. 2011;223:102–15.
pubmed: 21125669
doi: 10.1002/path.2806
Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004.
pubmed: 29263891
pmcid: 5661652
doi: 10.1038/sigtrans.2015.4
Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, et al. Melanoma. Nat Rev Dis Prim. 2015;1:15003.
pubmed: 27188223
doi: 10.1038/nrdp.2015.3
Xu Y, Brenn T, Brown ERS, Doherty V, Melton DW. Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors. Br J Cancer. 2012;106:553–61.
pubmed: 22223089
pmcid: 3273359
doi: 10.1038/bjc.2011.568
Aksenenko M, Palkina N, Komina A, Tashireva L, Ruksha T. Differences in microRNA expression between melanoma and healthy adjacent skin. BMC Dermatol. 2019;19:1.
pubmed: 30611259
pmcid: 6321655
doi: 10.1186/s12895-018-0081-1
Qian H, Yang C, Yang Y. MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene. Cell Death Disco. 2017;3:17028.
doi: 10.1038/cddiscovery.2017.28
Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S, et al. Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma. Cell Death Differ. 2019;26:1267–82.
pubmed: 30254376
doi: 10.1038/s41418-018-0205-5
Gebert LFR, MacRae IJ. Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2019;20:21–37.
pubmed: 30108335
pmcid: 6546304
doi: 10.1038/s41580-018-0045-7
Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet. 2015;16:1–13.
doi: 10.1038/nrg3965
Quévillon Huberdeau M, Simard MJ. A guide to microRNA-mediated gene silencing. FEBS J. 2019;286:642–52.
pubmed: 30267606
doi: 10.1111/febs.14666
Nam JW, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2014;53:1031–43.
pubmed: 24631284
pmcid: 4062300
doi: 10.1016/j.molcel.2014.02.013
van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644–56.
pubmed: 21822212
doi: 10.1038/nrc3107
Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer. 2017;3:506–28.
pubmed: 28718405
doi: 10.1016/j.trecan.2017.05.003
Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet. 2007;8:533–43.
pubmed: 17572691
doi: 10.1038/nrg2111
Kishore S, Luber S, Zavolan M. Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression. Brief Funct Genomics. 2010;9:391–404.
pubmed: 21127008
pmcid: 3080770
doi: 10.1093/bfgp/elq028
Jiang P, Coller H. Functional interactions between micro-RNAs and RNA binding proteins. Microrna. 2012;1:70–79.
pubmed: 25048093
pmcid: 5123774
doi: 10.2174/2211536611201010070
Iadevaia V, Gerber AP. Combinatorial control of mRNA fates by RNA-binding proteins and non-coding RNAs. Biomol Ther. 2015;5:2207–22.
Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell. 2006;125:1111–24.
pubmed: 16777601
doi: 10.1016/j.cell.2006.04.031
Ahuja D, Goyal A, Ray PS. Interplay between RNA-binding protein HuR and microRNA-125b regulates p53 mRNA translation in response to genotoxic stress. RNA Biol. 2016;13:1152–65.
pubmed: 27592685
pmcid: 5100343
doi: 10.1080/15476286.2016.1229734
Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev. 2009;23:1743–8.
pubmed: 19574298
pmcid: 2720259
doi: 10.1101/gad.1812509
Kedde M, van Kouwenhove M, Zwart W, Oude Vrielink JA, Elkon R, Agami R. Pumilio-induced RNA structure switch in p27-3’ UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol. 2010;12:1014–20.
pubmed: 20818387
doi: 10.1038/ncb2105
Kundu P, Fabian MR, Sonenberg N, Bhattacharyya SN, Filipowicz W. HuR protein attenuates miRNA-mediated repression by promoting miRISC dissociation from the target RNA. Nucleic Acids Res. 2012;40:5088–100.
pubmed: 22362743
pmcid: 3367187
doi: 10.1093/nar/gks148
Li Y, Estep JA, Karginov FV. Transcriptome wide Identification and Validation of Interactions between the miRNA Machinery and HuR on mRNA Targets. J Mol Biol. 2017;430:285–96.
pubmed: 29273203
doi: 10.1016/j.jmb.2017.12.006
Sternburg EL, Estep JA, Nguyen DK, Li Y, Karginov FV. Antagonistic and co-operative AGO2-PUM interactions in regulating mRNAs. Sci Rep. 2018;8:15316.
pubmed: 30333515
pmcid: 6192998
doi: 10.1038/s41598-018-33596-4
Kelly TJ, Suzuki HI, Zamudio JR, Suzuki M, Sharp PA. Sequestration of microRNA-mediated target repression by the Ago2-associated RNA binding protein FAM120A. RNA. 2019;25:1291–7.
pubmed: 31289130
pmcid: 6800481
doi: 10.1261/rna.071621.119
Mihailovich M, Militti C, Gabaldón T, Gebauer F. Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression. BioEssays. 2010;32:109–18.
pubmed: 20091748
doi: 10.1002/bies.200900122
Hollmann NM, Jagtap PKA, Masiewicz P, Guitart T, Simon B, Provaznik J, et al. Pseudo-RNA-binding domains mediate RNA structure specificity in upstream of N-Ras. Cell Rep. 2020;32:107930.
pubmed: 32697992
pmcid: 7383231
doi: 10.1016/j.celrep.2020.107930
Abaza I, Coll O, Patalano S, Gebauer F. Drosophila UNR is required for translational repression of male-specific lethal 2 mRNA during regulation of X-chromosome dosage compensation. Genes Dev. 2006;20:380–9.
pubmed: 16452509
pmcid: 1361708
doi: 10.1101/gad.371906
Duncan K, Grskovic M, Strein C, Beckmann K, Niggeweg R, Abaza I, et al. Sex-lethal imparts a sex-specific function to UNR by recruiting it to the msl-2 mRNA 3′ UTR: translational repression for dosage compensation. Genes Dev. 2006;20:368–79.
pubmed: 16452508
pmcid: 1361707
doi: 10.1101/gad.371406
Dormoy-Raclet V, Markovits J, Jacquemin-Sablon A, Jacquemin-Sablon H. Regulation of Unr expression by 5′- and 3′-untranslated regions of its mRNA through modulation of stability and IRES mediated translation. RNA Biol. 2005;2:e27–35.
pubmed: 17114922
doi: 10.4161/rna.2.3.2203
Schepens B, Tinton SA, Bruynooghe Y, Parthoens E, Haegman M, Beyaert R, et al. A role for hnRNP C1/C2 and Unr in internal initiation of translation during mitosis. EMBO J. 2007;26:158–69.
pubmed: 17159903
doi: 10.1038/sj.emboj.7601468
Mitchell SA, Brown EC, Coldwell MJ, Jackson RJ, Willis AE. Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras. Mol Cell Biol. 2001;21:3364–74.
pubmed: 11313462
pmcid: 100258
doi: 10.1128/MCB.21.10.3364-3374.2001
Cornelis S, Tinton SA, Schepens B, Bruynooghe Y, Beyaert R. UNR translation can be driven by an IRES element that is negatively regulated by polypyrimidine tract binding protein. Nucleic Acids Res. 2005;33:3095–108.
pubmed: 15928332
pmcid: 1142345
doi: 10.1093/nar/gki611
Dinur M, Kilav R, Sela-Brown A, Jacquemin-Sablon H, Naveh-Many T. In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability. Mol Endocrinol. 2006;20:1652–60.
pubmed: 16469771
doi: 10.1210/me.2005-0333
Lee HJ, Bartsch D, Xiao C, Guerrero S, Ahuja G, Schindler C, et al. A post-transcriptional program coordinated by CSDE1 prevents intrinsic neural differentiation of human embryonic stem cells. Nat Commun. 2017;8:1456.
doi: 10.1038/s41467-017-01744-5
Elatmani H, Dormoy-Raclet V, Dubus P, Dautry F, Chazaud C, Jacquemin-Sablon H. The RNA-binding protein Unr prevents mouse embryonic stem cells differentiation toward the primitive endoderm lineage. Stem Cell Rep. 2011;29:1504–16.
Kakumani PK, Harvey LM, Houle F, Guitart T, Gebauer F, Simard MJ. CSDE1 controls gene expression through the miRNA-mediated decay machinery. Life Sci Alliance. 2020;3:e201900632.
pubmed: 32161113
pmcid: 7067469
doi: 10.26508/lsa.201900632
Wurth L, Papasaikas P, Olmeda D, Bley N, Calvo GT, Guerrero S, et al. UNR/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis. Cancer Cell. 2016;30:694–707.
pubmed: 27908735
doi: 10.1016/j.ccell.2016.10.004
Fournier PG, Juárez P, Jiang G, Clines GA, Niewolna M, Kim HS, et al. The TGF-β signaling regulator PMEPA1 suppresses prostate cancer metastases to bone. Cancer Cell. 2015;27:809–21.
pubmed: 25982816
pmcid: 4464909
doi: 10.1016/j.ccell.2015.04.009
Amalia R, Abdelaziz M, Puteri MU, Hwang J, Anwar F, Watanabe Y, et al. TMEPAI/PMEPA1 inhibits Wnt signaling by regulating β-catenin stability and nuclear accumulation in triple negative breast cancer cells. Cell Signal. 2019;59:24–33.
pubmed: 30890370
doi: 10.1016/j.cellsig.2019.03.016
Abdelaziz M, Watanabe Y, Kato M. PMEPA1/TMEPAI knockout impairs tumour growth and lung metastasis in MDA-MB-231 cells without changing monolayer culture cell growth. J Biochem. 2019;165:411–4.
pubmed: 30873542
doi: 10.1093/jb/mvz022
Vo Nguyen TT, Watanabe Y, Shiba A, Noguchi M, Itoh S, Kato M. TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells. Cancer Sci. 2014;105:334–41.
pubmed: 24438557
pmcid: 4317935
doi: 10.1111/cas.12355
Connerty P, Ahadi A, Hutvagner G. RNA binding proteins in the miRNA pathway. Int J Mol Sci. 2015;17:E31.
pubmed: 26712751
doi: 10.3390/ijms17010031
Jannot G, Vasquez-Rifo A, Simard MJ. Argonaute pull-down and RISC analysis using 2’-O-methylated oligonucleotides affinity matrices. Methods Mol Biol. 2011;725:233–49.
pubmed: 21528458
doi: 10.1007/978-1-61779-046-1_16
Golden RJ, Chen B, Li T, Braun J, Manjunath H, Chen X, et al. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing. Nature. 2017;542:197–202.
pubmed: 28114302
pmcid: 5302127
doi: 10.1038/nature21025
Quévillon Huberdeau M, Zeitler DM, Hauptmann J, Bruckmann A, Fressigné L, Danner J, et al. Phosphorylation of Argonaute proteins affects mRNA binding and is essential for microRNA-guided gene silencing in vivo. EMBO J. 2017;36:2088–106.
pubmed: 28645918
pmcid: 5510005
doi: 10.15252/embj.201696386
Karginov FV, Hannon GJ. Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 2013;27:1624–32.
pubmed: 23824327
pmcid: 3731550
doi: 10.1101/gad.215939.113
Feng S, Zhu X, Fan B, Xie D, Li T, Zhang X. miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion. Mol Med Rep. 2016;13:4030–8.
pubmed: 27035427
doi: 10.3892/mmr.2016.5033
Agarwal V, Bell GW, Nam J, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.
pmcid: 4532895
doi: 10.7554/eLife.05005
Abaza I, Gebauer F. Functional domains of Drosophila UNR in translational control. RNA. 2008;14:482–90.
pubmed: 18203923
pmcid: 2248260
doi: 10.1261/rna.802908
Kamenska A, Simpson C, Vindry C, Broomhead H, Bénard M, Ernoult-Lange M, et al. The DDX6-4E-T interaction mediates translational repression and P-body assembly. Nucleic Acids Res. 2016;44:6318–34.
pubmed: 27342281
pmcid: 5291280
doi: 10.1093/nar/gkw565
Ji J, Ding K, Luo T, Xu R, Zhang X, Huang B, et al. PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1. Oncogene. 2020;39:1125–39.
pubmed: 31605013
doi: 10.1038/s41388-019-1050-9
Militti C, Maenner S, Becker PB, Gebauer F. UNR facilitates the interaction of MLE with the lncRNA roX2 during Drosophila dosage compensation. Nat Commun. 2014;5:4762.
pubmed: 25158899
doi: 10.1038/ncomms5762
Chang TC, Yamashita A, Chen CY, Yamashita Y, Zhu W, Durdan S, et al. UNR, a new partner of poly(A)-binding protein, plays a key role in translationally coupled mRNA turnover mediated by the c-fos major coding-region determinant. Genes Dev. 2004;18:2010–23.
pubmed: 15314026
pmcid: 514181
doi: 10.1101/gad.1219104
Kaye JA, Rose NC, Goldsworthy B, Goga A, L’Etoile ND. A 3′UTR pumilio-binding element directs translational activation in olfactory sensory neurons. Neuron. 2009;61:57–70.
pubmed: 19146813
pmcid: 4274156
doi: 10.1016/j.neuron.2008.11.012
Friend K, Campbell ZT, Cooke A, Kroll-Conner P, Wickens MP, Kimble J. A conserved PUF-Ago-eEF1A complex attenuates translation elongation. Nat Struct Mol Biol. 2012;19:176–83.
pubmed: 22231398
pmcid: 3293257
doi: 10.1038/nsmb.2214
Bohn JA, Van Etten JL, Schagat TL, Bowman BM, McEachin RC, Freddolino PL, et al. Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins. Nucleic Acids Res. 2018;46:362–86.
pubmed: 29165587
doi: 10.1093/nar/gkx1120
Fishbein L, Leshchiner I, Walter V, Danilova L, Robertson AG, Johnson AR, et al. Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell. 2017;31:181–93.
pubmed: 28162975
pmcid: 5643159
doi: 10.1016/j.ccell.2017.01.001
Martinez-Useros J, Garcia-Carbonero N, Li W, Fernandez-Aceñero MJ, Cristobal I, Rincon R, et al. UNR/ CSDE1 expression is critical to maintain invasive phenotype of colorectal cancer through regulation of c-MYC and epithelial-to-mesenchymal transition. J Clin Med. 2019;8:560.
pmcid: 6517883
doi: 10.3390/jcm8040560
Young LE, Moore AE, Sokol L, Meisner-Kober N, Dixon DA. The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2. Mol Cancer Res. 2012;10:167–80.
pubmed: 22049153
doi: 10.1158/1541-7786.MCR-11-0337
Bottini S, Hamouda-Tekaya N, Mategot R, Zaragosi LE, Audebert S, Pisano S. et al. Post-transcriptional gene silencing mediated by microRNAs is controlled by nucleoplasmic Sfpq. Nat Commun. 2017;8:1189
pubmed: 29084942
pmcid: 5662751
doi: 10.1038/s41467-017-01126-x
Xue Y, Ouyang K, Huang J, Zhou Y, Ouyang H, Li H, et al. Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits. Cell. 2013;152:82–96.
pubmed: 23313552
pmcid: 3552026
doi: 10.1016/j.cell.2012.11.045
Kedde M, Strasser MJ, Boldajipour B, Oude Vrielink JA, Slanchev K, le Sage C, et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell. 2017;131:1273–86.
doi: 10.1016/j.cell.2007.11.034
Liu Q, Jiang J, Fu Y, Liu T, Yu Y, Zhang X. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9. Biomed Pharmacother. 2018;105:420–7.
pubmed: 29879625
doi: 10.1016/j.biopha.2018.05.105
Wang S, Chen Y, Yu X, Lu Y, Wang H, Wu F, et al. miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer. Pathol Res Pr. 2019;215:676–82.
doi: 10.1016/j.prp.2018.12.024
Qiu Z, Wang X, Shi Y, Da M. miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Acta Biochim Biophys Sin (Shanghai). 2019;51:997–1007.
doi: 10.1093/abbs/gmz096
Li Z, Lu J, Zeng G, Pang J, Zheng X, Feng J, et al. MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4). Cell Death Dis. 2019;10:789.
pubmed: 31624237
pmcid: 6797732
doi: 10.1038/s41419-019-1923-4
Wan P, Bai X, Yang C, He T, Luo L, Wang Y, et al. miR-129-5p inhibits proliferation, migration, and invasion in rectal adenocarcinoma cells through targeting E2F7. J Cell Physiol. 2020;235:5689–701.
Li G, Xie J, Wang J. Tumor suppressor function of miR-129-5p in lung cancer. Oncol Lett. 2019;17:5777–83.
pubmed: 31186804
pmcid: 6507349
Ma L, Chen X, Li C, Cheng R, Gao Z, Meng X, et al. miR-129-5p and -3p co-target WWP1 to suppress gastric cancer proliferation and migration. J Cell Biochem. 2018;120:7527–38.
doi: 10.1002/jcb.28027
Goyer B, Pereira U, Magne B, Larouche D, Kearns‐Turcotte S, Rochette PJ, et al. Impact of ultraviolet radiation on dermal and epidermal DNA damage in a human pigmented bilayered skin substitute. J Tissue Eng Regen Med. 2019;13:2300–11.
pubmed: 31502756
doi: 10.1002/term.2959